Article | March 20, 2024

Top 10 Biologics Approved In 2023

Source: Mabion

By Adam Tuszyner, Registration Documentation Specialist, Pharmacovigilance Specialist

GettyImages-1444062860 nurse patient clinical

In the previous year, a significant number of new biologic drugs were approved by regulatory agencies, with 18 approved by the EMA and 34 approved by the FDA. These drugs cover a wide range of therapeutic areas and utilize innovative technologies.

This article highlights 10 of the most important drugs that have the potential to revolutionize medical practice, including protein vaccines against RSV, bispecific antibodies for treatment-resistant cancers, and CRISPR/Cas9-based gene therapy for sickle cell anemia. Access the full article for a brief overview of each drug and its indications.

Additionally, there are expected to be more groundbreaking biologics approved in 2024 that can reshape medical practice and offer hope to patients.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Biosimilar Development